Although toxic shock syndrome (TSS) is rare, multiorgan failure can occur without early identification and appropriate therapy. In particular, a few cases of postpartum TSS due to methicillin‐resistant Staphylococcus aureus (MRSA) have been reported. Here, we describe a rare case in which a 32‐year‐old Japanese woman had TSS due to MRSA that was caused by a perineal infection after a normal vaginal delivery. Twelve days after giving birth to a healthy child, she was readmitted to our hospital due to a 2‐day fever and perineal pain without uterine tenderness. She developed emesis and watery diarrhea on the night of admission. On the second day, a diffuse cutaneous macular rash appeared over her trunk. Laboratory data revealed deteriorated renal function and thrombocytopenia. Her history and clinical results were compatible with a typical course of TSS. Administration of ceftriaxone and clindamycin was started immediately after admission and was effective. The patient recuperated steadily over the next week with desquamation of the skin. MRSA was isolated from her vaginal discharge and was found to produce TSS toxin 1 (TSST‐1). Furthermore, since MRSA was not detected in the nasal and vaginal cavity during pregnancy, it suggests that vaginal colonization can also occur postpartum and be the disease source in mothers. Therefore, MRSA infections should be considered when treating for postpartum TSS.
15 November 2025 in Archives of Clinical Obstetrics and Gynecology Research
Spontaneous rupture of the urinary bladder is a rare event that may be caused by prior radiotherapy, bladder dysfunction, alcoholic intoxication, cancer invasion, and inflammation. We herein describe a 58-year-old woman diagnosed with spontaneous bladder rupture presenting with a urinary-cutaneous fistula during chemotherapy for peritoneal cancer. Twenty-five years ago, the patient underwent radical hysterectomy followed by radiotherapy for cervical cancer and developed neurogenic bladder. She was referred to our hospital due to pleural effusion and ascites. After exploratory laparotomy, she was diagnosed with stage IVB peritoneal cancer. She received chemotherapy with paclitaxel and carboplatin. While chemotherapy was effective, she was hospitalized for left pyelonephritis and septic shock. After receiving antibiotics, she was recommended for self-catheterization for urination. After the fifth course of chemotherapy, she presented with a large amount of fluid leaking from the lower part of her abdominal wound. Computed Tomography (CT) and cystography suggested that extraperitoneal rupture of the urinary bladder had led to an abscess of the space of Retzius, with urine and pus leaking from the urinary-cutaneous fistula. A urinary balloon catheter was placed and the deep abscess cavity was washed out. After 2.5 months, both the extraperitoneal bladder rupture and the fistula resolved with conservative management. Two years after resuming chemotherapy, the patient died from the progression of peritoneal cancer.
Background: Epithelial ovarian cancer (EOC) is characterized by aggressive peritoneal dissemination and an immunosuppressive tumor microenvironment in which tumor-associated macrophages (TAMs) play a central role. Chemokine signaling pathways regulate macrophage recruitment and function; however, the contribution of the CX3CL1–CX3CR1 axis to ovarian cancer progression and TAM-mediated effector mechanisms remains unclarified. This study aimed to clarify the role of CX3CL1–CX3CR1 signaling in ovarian cancer progression, focusing on macrophage-derived pro-tumorigenic factors. Methods: CX3CL1 and CX3CR1 expression was examined in human EOC and healthy ovarian tissues by real-time polymerase chain reaction and immunohistochemistry. Functional effects of CX3CL1 on ovarian cancer cells were evaluated via migration and proliferation assays in the murine ID8 cell line. An intraperitoneal syngeneic ovarian cancer model was established by injecting ID8 cells into wild-type and Cx3cr1-deficient mice. Tumor burden, ascites formation, survival, macrophage infiltration, and expression levels of matrix metalloprotease-2 (MMP-2) and transforming growth factor-β (TGF-β) were assessed by histological, immunohistochemical, and molecular analyses. Results: CX3CL1 and CX3CR1 expression was significantly upregulated in human EOC tissues and associated with marked macrophage infiltration. CX3CL1 stimulation enhanced migration, but not proliferation, of ID8 cells. Cx3cr1 deficiency significantly suppressed intraperitoneal tumor growth, reduced ascitic fluid volume, and prolonged survival. This was accompanied by reduced CX3CR1+ TAM accumulation and decreased MMP-2 and TGF-β expression, which were predominantly produced by infiltrating macrophages. Conclusions: The CX3CL1–CX3CR1 axis promotes ovarian cancer progression by recruiting MMP-2- and TGF-β-producing macrophages. Targeting CX3CR1-dependent TAM functions may represent a therapeutic strategy for limiting peritoneal dissemination in ovarian cancer.